These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35411052)

  • 1. Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson's disease.
    Pereira PAB; Trivedi DK; Silverman J; Duru IC; Paulin L; Auvinen P; Scheperjans F
    NPJ Parkinsons Dis; 2022 Apr; 8(1):39. PubMed ID: 35411052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Omics Integration in Mice With Parkinson's Disease and the Intervention Effect of Cyanidin-3-
    Wang W; Zhu G; Wang Y; Li W; Yi S; Wang K; Fan L; Tang J; Chen R
    Front Aging Neurosci; 2022; 14():877078. PubMed ID: 35572129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
    Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
    Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
    Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson's Disease.
    Cerroni R; Pietrucci D; Teofani A; Chillemi G; Liguori C; Pierantozzi M; Unida V; Selmani S; Mercuri NB; Stefani A
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.
    van Kessel SP; El Aidy S
    J Parkinsons Dis; 2019; 9(s2):S359-S370. PubMed ID: 31609701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease.
    Cirstea MS; Yu AC; Golz E; Sundvick K; Kliger D; Radisavljevic N; Foulger LH; Mackenzie M; Huan T; Finlay BB; Appel-Cresswell S
    Mov Disord; 2020 Jul; 35(7):1208-1217. PubMed ID: 32357258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates.
    Cosma-Grigorov A; Meixner H; Mrochen A; Wirtz S; Winkler J; Marxreiter F
    Front Neurol; 2020; 11():1041. PubMed ID: 33071933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
    Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
    Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease.
    Ren T; Gao Y; Qiu Y; Jiang S; Zhang Q; Zhang J; Wang L; Zhang Y; Wang L; Nie K
    Front Neurol; 2020; 11():137. PubMed ID: 32161568
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
    Boertien JM; Murtomäki K; Pereira PAB; van der Zee S; Mertsalmi TH; Levo R; Nojonen T; Mäkinen E; Jaakkola E; Laine P; Paulin L; Pekkonen E; Kaasinen V; Auvinen P; Scheperjans F; van Laar T;
    NPJ Parkinsons Dis; 2022 Oct; 8(1):129. PubMed ID: 36216843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study.
    Zapała B; Stefura T; Wójcik-Pędziwiatr M; Kabut R; Bałajewicz-Nowak M; Milewicz T; Dudek A; Stój A; Rudzińska-Bar M
    J Clin Med; 2021 Dec; 10(23):. PubMed ID: 34884399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
    Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
    BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
    Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
    Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the characteristics of the intestinal flora in patients with Parkinson's disease complicated with constipation.
    Chen W; Bi Z; Zhu Q; Gao H; Fan Y; Zhang C; Liu X; Ye M
    Am J Transl Res; 2021; 13(12):13710-13722. PubMed ID: 35035709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis.
    Shen T; Yue Y; He T; Huang C; Qu B; Lv W; Lai HY
    Front Aging Neurosci; 2021; 13():636545. PubMed ID: 33643026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ; Chen CC; Liao HY; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    J Parkinsons Dis; 2022; 12(4):1219-1230. PubMed ID: 35342048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.